Decentralized Clinical Trials (DCTs) reduce the operational load on investigator sites while expanding access to more patients — making clinical research simpler to run and easier to sustain.
In a traditional clinical trial, participants must travel repeatedly to a central site — creating scheduling burdens, dropout risk, and geographic barriers. Decentralized Clinical Trials change that model: leveraging telemedicine, remote monitoring, wearables, and local healthcare providers to bring trial activities directly to participants.
For investigator sites, this means fewer in-person logistics, less scheduling strain, and the ability to manage more participants without proportionally expanding staff or space. DCTs don’t eliminate the site — they make the site more efficient.
From reduced operational overhead to richer data, decentralized trials offer measurable improvements at every stage of study conduct.
Remote follow-up visits, eConsent, and digital data collection reduce the volume of in-person coordination your team handles — freeing staff for higher-value activities and making research sustainable long-term.
Reach participants across wider geographies — including underserved populations and those with mobility limitations — without requiring them to travel repeatedly to your location.
Wearables, digital diaries, and remote monitoring tools capture data continuously and accurately — eliminating recall bias and reducing source data errors between on-site visits.
Participants who can engage from home drop out far less frequently. DCTs consistently demonstrate better long-term engagement, protecting your trial’s enrollment targets and data integrity.
Reduced need for physical infrastructure, streamlined scheduling, and faster enrollment timelines translate to lower per-patient costs and shorter overall trial durations for sites and sponsors alike.
The FDA’s 2024 final guidance formally endorses decentralized elements — giving sites and sponsors a clear, supported framework to design and execute DCT protocols with confidence.
DCTs aren’t one-size-fits-all. From fully remote studies to hybrid designs with select on-site visits, the model adapts to your protocol — and Medinexo helps you navigate which approach fits best.
eConsent platforms enable participants to review and sign informed consent from home — reducing your site’s administrative load before a single on-site visit occurs.
Routine assessments, lab draws, and medication delivery shift to local providers or home health nurses — minimizing on-site footprint without sacrificing clinical oversight.
Wearables, patient-reported outcome apps, and telemedicine platforms capture continuous, high-quality data between visits — feeding directly into your trial’s data systems in real time.
Your site retains clinical oversight and regulatory responsibility — focusing time on critical assessments while remote elements handle routine touchpoints efficiently.
For practices exploring clinical research for the first time, DCTs dramatically lower the barrier to entry. No need to build out a full research infrastructure from day one. Medinexo connects investigator sites to DCT-compatible trials through the ResearchNexo network — and supports you through every step of getting ready to participate.
DCT Trial Matching — We connect your site to sponsors running decentralized or hybrid protocols that fit your patient population and existing capacity.
Site Readiness Support — Through our ResearchNexo Site Readiness program, we prepare your site operationally — documentation, credentials, and workflow — before the first study arrives.
Patient Mapping — Our ICD-10 diagnostic matching identifies which of your existing patients are eligible for active DCT trials — so enrollment starts faster with patients you already know.
Network Visibility — Your site gains a verified profile visible to sponsor and CRO teams actively seeking DCT-capable investigator sites.
Ongoing Coaching — A dedicated Medinexo advisor supports your team through every phase, from initial DCT setup through study completion.
Whether you’re new to clinical research or looking to expand your site’s trial portfolio with less operational strain, Medinexo can help you take the next step.
Get Started →